These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
122 related articles for article (PubMed ID: 38703746)
1. Innovative LC-MS/MS method for therapeutic drug monitoring of fenfluramine and cannabidiol in the plasma of pediatric patients with epilepsy. Pigliasco F; Cafaro A; Barco S; Stella M; Mattioli F; Riva A; Mancardi MM; Lattanzi S; Bandettini R; Striano P; Cangemi G J Pharm Biomed Anal; 2024 Aug; 245():116174. PubMed ID: 38703746 [TBL] [Abstract][Full Text] [Related]
2. Therapeutic drug monitoring of fenfluramine in clinical practice: Pharmacokinetic variability and impact of concomitant antiseizure medications. Schoonjans AS; Roosens L; Dewals W; Paelinck BP; Ceulemans B Epilepsia; 2022 Mar; 63(3):686-696. PubMed ID: 35032026 [TBL] [Abstract][Full Text] [Related]
3. An Ultrafast Ultrahigh-Performance Liquid Chromatography Coupled With Tandem Mass Spectrometry Method for Cannabidiol Monitoring in Pediatric Refractory Epilepsy. Pérez Montilla CA; Schaiquevich PS; Cáceres Guido P; Caraballo RH; Reyes Valenzuela G; Cruz CV; García Bournissen F Ther Drug Monit; 2021 Oct; 43(5):712-717. PubMed ID: 33346629 [TBL] [Abstract][Full Text] [Related]
4. Therapeutic Drug Monitoring of Phenytoin by Simple, Rapid, Accurate, Highly Sensitive and Novel Method and Its Clinical Applications. Shaikh AS; Guo R Curr Pharm Biotechnol; 2017; 18(13):1098-1105. PubMed ID: 29437004 [TBL] [Abstract][Full Text] [Related]
5. Cannabidiol Determination on Peripheral Capillary Blood Using a Microsampling Method and Ultra-High-Performance Liquid Chromatography Tandem Mass Spectrometry with On-Line Sample Preparation. Pigliasco F; Barco S; Dubois S; Marchese F; Striano P; Lomonaco T; Mattioli F; Tripodi G; Cangemi G Molecules; 2020 Aug; 25(16):. PubMed ID: 32784413 [TBL] [Abstract][Full Text] [Related]
6. Simultaneous Quantification of Ivacaftor, Tezacaftor, and Elexacaftor in Cystic Fibrosis Patients' Plasma by a Novel LC-MS/MS Method. Pigliasco F; Cafaro A; Stella M; Baiardi G; Barco S; Pedemonte N; D'Orsi C; Cresta F; Casciaro R; Castellani C; Calevo MG; Mattioli F; Cangemi G Biomedicines; 2023 Feb; 11(2):. PubMed ID: 36831163 [TBL] [Abstract][Full Text] [Related]
7. Efficacy of Fenfluramine and Norfenfluramine Enantiomers and Various Antiepileptic Drugs in a Zebrafish Model of Dravet Syndrome. Li J; Nelis M; Sourbron J; Copmans D; Lagae L; Cabooter D; de Witte PAM Neurochem Res; 2021 Sep; 46(9):2249-2261. PubMed ID: 34041623 [TBL] [Abstract][Full Text] [Related]
8. On-Line Solid Phase Extraction High Performance Liquid Chromatography Method Coupled With Tandem Mass Spectrometry for the Therapeutic Monitoring of Cannabidiol and 7-Hydroxy-cannabidiol in Human Serum and Saliva. Franco V; Palmisani M; Marchiselli R; Crema F; Fattore C; De Giorgis V; Varesio C; Rota P; Dibari VF; Perucca E Front Pharmacol; 2022; 13():915004. PubMed ID: 35814197 [TBL] [Abstract][Full Text] [Related]
9. A Liquid Chromatography-Mass Spectrometry Assay for Determination of Perampanel and Concomitant Antiepileptic Drugs in the Plasma of Patients With Epilepsy Compared With a Fluorescent HPLC Assay. de Grazia U; DʼUrso A; Ranzato F; De Riva V; Contarato G; Billo G; Perini F; Galloni E Ther Drug Monit; 2018 Aug; 40(4):477-485. PubMed ID: 29746395 [TBL] [Abstract][Full Text] [Related]
10. A UHPLC-MS/MS method for the quantification of Δ9-tetrahydrocannabinol and cannabidiol in decoctions and in plasma samples for therapeutic monitoring of medical cannabis. Barco S; Fucile C; Manfredini L; De Grandis E; Gherzi M; Martelli A; Tripodi G; Mattioli F; Cangemi G Bioanalysis; 2018 Dec; 10(24):2003-2014. PubMed ID: 30412688 [No Abstract] [Full Text] [Related]
11. Quantification of levetiracetam in human plasma by liquid chromatography-tandem mass spectrometry: application to therapeutic drug monitoring. Matar KM J Pharm Biomed Anal; 2008 Nov; 48(3):822-8. PubMed ID: 18603399 [TBL] [Abstract][Full Text] [Related]
12. LC-MS/MS-Based Quantification of 9 Antiepileptic Drugs From a Dried Sample Spot Device. DʼUrso A; Cangemi G; Barco S; Striano P; DʼAvolio A; de Grazia U Ther Drug Monit; 2019 Jun; 41(3):331-339. PubMed ID: 30688867 [TBL] [Abstract][Full Text] [Related]
13. A UHPLC-MS/MS Method for Therapeutic Drug Monitoring of Aciclovir and Ganciclovir in Plasma and Dried Plasma Spots. Pigliasco F; Cafaro A; Simeoli R; Barco S; Magnasco A; Faraci M; Tripodi G; Goffredo BM; Cangemi G Biomedicines; 2021 Oct; 9(10):. PubMed ID: 34680495 [TBL] [Abstract][Full Text] [Related]
14. Dried plasma spot as an innovative approach to therapeutic drug monitoring of apixaban: Development and validation of a novel liquid chromatography-tandem mass spectrometry method. Cafaro A; Stella M; Baiardi G; Barco S; Pigliasco F; Bandettini R; Nanni L; Mattioli F; Cangemi G J Mass Spectrom; 2024 Sep; 59(9):e5081. PubMed ID: 39187037 [TBL] [Abstract][Full Text] [Related]
15. A validated method for the simultaneous quantification of cannabidiol, Δ Kevin RC; Vogel R; Doohan P; Berger M; Amminger GP; McGregor IS Drug Test Anal; 2021 Mar; 13(3):614-627. PubMed ID: 33095968 [TBL] [Abstract][Full Text] [Related]
16. Validation and clinical application of a multiplex high performance liquid chromatography - tandem mass spectrometry assay for the monitoring of plasma concentrations of 12 antibiotics in patients with severe bacterial infections. Decosterd LA; Mercier T; Ternon B; Cruchon S; Guignard N; Lahrichi S; Pesse B; Rochat B; Burger R; Lamoth F; Pagani JL; Eggimann P; Csajka C; Choong E; Buclin T; Widmer N; André P; Marchetti O J Chromatogr B Analyt Technol Biomed Life Sci; 2020 Nov; 1157():122160. PubMed ID: 32891946 [TBL] [Abstract][Full Text] [Related]
17. A liquid chromatography-tandem mass spectrometry platform for the routine therapeutic drug monitoring of 14 antibiotics: Application to critically ill pediatric patients. Barco S; Mesini A; Barbagallo L; Maffia A; Tripodi G; Pea F; Saffioti C; Castagnola E; Cangemi G J Pharm Biomed Anal; 2020 Jul; 186():113273. PubMed ID: 32251979 [TBL] [Abstract][Full Text] [Related]
18. UHPLC-MS/MS Analysis of Cannabidiol and Its Metabolites in Serum of Patients with Resistant Epilepsy Treated with CBD Formulations. Malaca S; Gottardi M; Pigliasco F; Barco S; Cafaro A; Amadori E; Riva A; Marcenaro M; Striano P; Cangemi G; Pacifici R; Pichini S; Busardò FP Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34209666 [TBL] [Abstract][Full Text] [Related]
19. A Volumetric Absorptive Microsampling Technique to Monitor Cannabidiol Levels in Epilepsy Patients. Dubois S; Marchese F; Pigliasco F; Barco S; Tripodi G; Lomonaco T; Lattanzi S; Russo E; Cangemi G; Striano P Front Pharmacol; 2020; 11():582286. PubMed ID: 33364956 [No Abstract] [Full Text] [Related]
20. Development and Validation of an UHPLC-MS/MS Assay for the Therapeutic Monitoring of Brivaracetam Plasma Concentrations in Patients with Epilepsy. Mohamed S; Riva R; Contin M Ther Drug Monit; 2020 Jun; 42(3):445-451. PubMed ID: 31934942 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]